DIS analyst scorecard · Walt Disney Company (The)
43 rating actions on DIS in the last 12 months. Of 64 price targets that resolved, 8 were reached while they stood, 46 were replaced by the same firm first, and 10 fell short at their deadline. Ratings: 98% Buy-type, 2% Hold-type, 0% Sell-type. Consensus target $127, 14% above the last close.
Checked through 2026-10-29 · last close $110.97 (2026-10-29). Rebuilt every morning.
What the Holds say: 1 Hold-type ratings on DIS in the last 12 months carried a median target +18% from the price on the day; 0% sat below it.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| Barclays | Overweight | 2026-08-06 | $115 | 1 | 5 | 6 | 0 of 1 |
| Guggenheim | Buy | 2026-09-28 | $120 | 1 | 6 | 7 | 0 of 1 |
| Wells Fargo | Overweight | 2026-08-06 | $132 | 0 | 7 | 7 | 0 of 1 |
| Needham | Buy | 2026-10-09 | $125 | 0 | 3 | 8 | 0 of 1 |
| Rosenblatt | Buy | 2026-08-06 | $126 | 0 | 6 | 6 | 0 of 1 |
| Benchmark | Buy | 2026-08-06 | $115 | — | — | 0 | — |
| Argus Research | Buy | 2026-08-06 | $134 | — | — | 0 | — |
| UBS | Buy | 2026-07-20 | $133 | 2 | 0 | 3 | 0 of 1 |
| Evercore ISI Group | Outperform | 2025-11-14 | $142 | 0 | 3 | 3 | 0 of 1 |
| Jefferies | Buy | 2026-02-03 | $132 | 0 | 2 | 2 | 0 of 1 |
| Citigroup | Buy | 2026-10-16 | $140 | 0 | 4 | 4 | 0 of 1 |
| Raymond James | Outperform | 2026-10-05 | $119 | 1 | 2 | 3 | — |
| JPMorgan | Overweight | 2026-06-30 | $140 | 0 | 3 | 3 | 0 of 1 |
| TD Cowen | Hold | 2026-02-03 | $123 | 1 | 0 | 1 | — |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor DIS carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-16 | Citigroup | Buy | maintained | $110.59 | $140 | running to 2027-10-16 | +3.4% |
| 2026-10-09 | Needham | Buy | reiterated | $108.05 | $125 | running to 2027-10-09 | +3.7% |
| 2026-10-05 | Raymond James | Outperform | maintained | $103.61 | $119 | running to 2027-10-05 | -1.6% |
| 2026-09-28 | Guggenheim | Buy | reiterated | $105.59 | $120 | running to 2027-09-28 | -2.3% |
| 2026-08-06 | Wells Fargo | Overweight | maintained | $104.68 | $132 | running to 2027-08-06 | +7.4% |
| 2026-08-06 | Argus Research | Buy | reiterated | $104.68 | $134 | running to 2027-08-06 | +7.4% |
| 2026-08-06 | Benchmark | Buy | reiterated | $104.68 | $115 | running to 2027-08-06 | +7.4% |
| 2026-08-06 | Barclays | Overweight | maintained | $104.68 | $115 | running to 2027-08-06 | +7.4% |
| 2026-08-06 | Guggenheim | Buy | reiterated | $104.68 | $120 | running to 2027-08-06 | +7.4% |
| 2026-08-06 | Rosenblatt | Buy | maintained | $104.68 | $126 | running to 2027-08-06 | +7.4% |
| 2026-07-29 | Citigroup | Buy | maintained | $98.48 | $135 | replaced 2026-10-16, new $140 | -0.1% |
| 2026-07-20 | UBS | Buy | maintained | $96.41 | $133 | running to 2027-07-20 | -7.2% |
| 2026-07-14 | Barclays | Overweight | maintained | $95.87 | $110 | replaced 2026-08-06, new $115 | -4.2% |
| 2026-07-13 | Benchmark | Buy | initiated | $96.00 | $115 | running to 2027-07-13 | -4.0% |
| 2026-07-13 | Wells Fargo | Overweight | maintained | $96.00 | $125 | replaced 2026-08-06, new $132 | -4.0% |
| 2026-07-07 | Rosenblatt | Buy | maintained | $97.48 | $126 | running to 2027-07-07 | -2.2% |
| 2026-07-02 | Raymond James | Outperform | maintained | $99.50 | $111 | reached 2026-08-25 | -1.9% |
| 2026-06-30 | JPMorgan | Overweight | maintained | $96.25 | $140 | running to 2027-06-30 | -5.5% |
| 2026-06-12 | Needham | Buy | reiterated | $100.04 | $125 | running to 2027-06-12 | -4.6% |
| 2026-06-05 | Rosenblatt | Buy | maintained | $99.71 | $126 | running to 2027-06-05 | -7.7% |
| 2026-05-23 | Raymond James | Outperform | maintained | $103.28 | $119 | replaced 2026-07-02, new $111 | -0.4% |
| 2026-05-08 | Citigroup | Buy | maintained | $108.02 | $145 | replaced 2026-07-29, new $135 | +8.9% |
| 2026-05-07 | JPMorgan | Overweight | maintained | $108.66 | $139 | replaced 2026-06-30, new $140 | +13.4% |
| 2026-05-07 | Barclays | Overweight | maintained | $108.66 | $135 | replaced 2026-07-14, new $110 | +13.4% |
| 2026-05-07 | Guggenheim | Buy | maintained | $108.66 | $120 | running to 2027-05-07 | +13.4% |
| 2026-05-07 | Wells Fargo | Overweight | maintained | $108.66 | $146 | replaced 2026-07-13, new $125 | +13.4% |
| 2026-04-08 | Barclays | Overweight | maintained | $99.18 | $130 | replaced 2026-05-07, new $135 | -2.4% |
| 2026-04-01 | Raymond James | Market Perform → Outperform | upgrade | $96.56 | $115 | replaced 2026-05-23, new $119 | -7.5% |
| 2026-03-31 | Needham | Buy | reiterated | $96.38 | $125 | running to 2027-03-31 | -9.1% |
| 2026-03-27 | Wells Fargo | Overweight | maintained | $92.42 | $148 | replaced 2026-05-07, new $146 | -12.0% |
| 2026-03-18 | Guggenheim | Buy | maintained | $99.42 | $115 | replaced 2026-05-07, new $120 | -5.7% |
| 2026-02-03 | Rosenblatt | Buy | maintained | $104.22 | $130 | replaced 2026-06-05, new $126 | -6.8% |
| 2026-02-03 | Guggenheim | Buy | reiterated | $104.22 | $140 | replaced 2026-03-18, new $115 | -6.8% |
| 2026-02-03 | TD Cowen | Hold | reiterated | $104.22 | $123 | running to 2027-02-03 | -6.8% |
| 2026-02-03 | Wells Fargo | Overweight | maintained | $104.22 | $150 | replaced 2026-03-27, new $148 | -6.8% |
| 2026-02-03 | Jefferies | Buy | maintained | $104.22 | $132 | running to 2027-02-03 | -6.8% |
| 2026-02-02 | Needham | Buy | reiterated | $104.45 | $125 | running to 2027-02-02 | -6.6% |
| 2026-01-16 | Citigroup | Buy | maintained | $111.20 | $140 | replaced 2026-05-08, new $145 | +0.5% |
| 2025-11-14 | Jefferies | Buy | maintained | $105.80 | $136 | replaced 2026-02-03, new $132 | — |
| 2025-11-14 | Wells Fargo | Overweight | maintained | $105.80 | $152 | replaced 2026-02-03, new $150 | — |
| 2025-11-14 | Guggenheim | Buy | reiterated | $105.80 | $140 | replaced 2026-03-18, new $115 | — |
| 2025-11-14 | Evercore ISI Group | Outperform | maintained | $105.80 | $142 | running to 2026-11-14 | — |
| 2025-11-13 | Needham | Buy | reiterated | $107.61 | $125 | running to 2026-11-13 | — |
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.